Unknown

Dataset Information

0

Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.


ABSTRACT: In search of redox mechanisms in breast cancer, we uncovered a striking role for glutathione peroxidase 2 (GPx2) in oncogenic signaling and patient survival. GPx2 loss stimulates malignant progression due to reactive oxygen species/hypoxia inducible factor-α (HIF1α)/VEGFA (vascular endothelial growth factor A) signaling, causing poor perfusion and hypoxia, which were reversed by GPx2 reexpression or HIF1α inhibition. Ingenuity Pathway Analysis revealed a link between GPx2 loss, tumor angiogenesis, metabolic modulation, and HIF1α signaling. Single-cell RNA analysis and bioenergetic profiling revealed that GPx2 loss stimulated the Warburg effect in most tumor cell subpopulations, except for one cluster, which was capable of oxidative phosphorylation and glycolysis, as confirmed by coexpression of phosphorylated-AMPK and GLUT1. These findings underscore a unique role for redox signaling by GPx2 dysregulation in breast cancer, underlying tumor heterogeneity, leading to metabolic plasticity and malignant progression.

SUBMITTER: Ren Z 

PROVIDER: S-EPMC8872779 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.

Ren Zuen Z   Liang Huizhi H   Galbo Phillip M PM   Dharmaratne Malindrie M   Kulkarni Ameya S AS   Fard Atefeh Taherian AT   Aoun Marie Louise ML   Martinez-Lopez Nuria N   Suyama Kimita K   Benard Outhiriaradjou O   Zheng Wei W   Liu Yang Y   Albanese Joseph J   Zheng Deyou D   Mar Jessica C JC   Singh Rajat R   Prystowsky Michael B MB   Norton Larry L   Hazan Rachel B RB  

Proceedings of the National Academy of Sciences of the United States of America 20220201 8


In search of redox mechanisms in breast cancer, we uncovered a striking role for glutathione peroxidase 2 (GPx2) in oncogenic signaling and patient survival. GPx2 loss stimulates malignant progression due to reactive oxygen species/hypoxia inducible factor-α (HIF1α)/VEGFA (vascular endothelial growth factor A) signaling, causing poor perfusion and hypoxia, which were reversed by GPx2 reexpression or HIF1α inhibition. Ingenuity Pathway Analysis revealed a link between GPx2 loss, tumor angiogenesi  ...[more]

Similar Datasets

| S-EPMC3838956 | biostudies-literature
| S-EPMC3195617 | biostudies-literature
| S-EPMC6823641 | biostudies-literature
| S-EPMC7435675 | biostudies-literature
| S-EPMC2673260 | biostudies-literature
| S-EPMC3769272 | biostudies-literature
| S-EPMC6906704 | biostudies-literature
| S-EPMC8256493 | biostudies-literature
| S-EPMC5127648 | biostudies-literature
| S-EPMC10178840 | biostudies-literature